We are live on
!
Find out more
GENE
Genetic Technologies Ltd.
GENE
GENE
Delisted
GENE was delisted on the 16th of October, 2024.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $242K | -$116K | -11,388 | -35% |
|
|
SFI
2
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| $147K | +$132K | +12,920 | New |
|
|
VF
3
Virtu Financial
New York
| $40K | +$36.1K | +3,538 | New |
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $34K | +$30.7K | +3,014 | New |
|
5
UBS Group
Zurich,
Switzerland
| $14K | +$12.3K | +1,203 | +8,020% |
|
6
Morgan Stanley
New York
| $11K | +$10.2K | +999 | New |
|
|
DCM
7
Davis Capital Management
Jacksonville,
Florida
| $2K | – | – | – |
|
|
CG
8
Cutler Group
San Francisco,
California
| $1K | – | – | – |
|
|
CAN
9
Cetera Advisor Networks
El Segundo,
California
| $1K | +$489 | +48 | New |
|
|
RE
10
RBC Europe
London,
United Kingdom
| $46 | – | – | – |
|